Omni Peptides
GHRP-6
Couldn't load pickup availability

Improves insulin sensitivity, endurance, metabolic health and hunger increase
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide and potent growth hormone secretagogue that acts as an agonist of the ghrelin receptor (GHS-R1a). This research compound has attracted substantial scientific interest for its strong stimulation of endogenous growth hormone (GH) release from the anterior pituitary, as well as its unique ability to markedly increase appetite via central hypothalamic pathways. Preliminary and advanced preclinical studies indicate that GHRP-6 may promote pulsatile GH secretion, enhance IGF-1 levels, support anabolic processes, accelerate tissue repair, and influence energy balance through both GH-dependent and GH-independent mechanisms. Researchers utilize GHRP-6 in laboratory and animal models to investigate mechanisms of GH axis activation, ghrelin signaling, appetite regulation, wound healing, and metabolic responses in contexts of growth, aging, catabolic states, and recovery. As a research-grade compound, GHRP-6 is intended exclusively for in vitro and animal studies. Scientists value its robust GH-releasing potency, pronounced orexigenic (appetite-stimulating) effect, and utility in studying the interplay between ghrelin receptor activation, growth hormone dynamics, and feeding behavior.
Research Applications
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.
— About this compound
GHRP-6 is a synthetic hexapeptide growth hormone secretagogue.
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide and potent growth hormone secretagogue that acts as an agonist of the ghrelin receptor (GHS-R1a). This research compound has attracted substantial scientific interest for its strong stimulation of endogenous growth hormone (GH) release from the anterior pituitary, as well as its unique ability to markedly increase appetite via central hypothalamic pathways. Preliminary and advanced preclinical studies indicate that GHRP-6 may promote pulsatile GH secretion, enhance IGF-1 levels, support anabolic processes, accelerate tissue repair, and influence energy balance through both GH-dependent and GH-independent mechanisms. Researchers utilize GHRP-6 in laboratory and animal models to investigate mechanisms of GH axis activation, ghrelin signaling, appetite regulation, wound healing, and metabolic responses in contexts of growth, aging, catabolic states, and recovery. As a research-grade compound, GHRP-6 is intended exclusively for in vitro and animal studies. Scientists value its robust GH-releasing potency, pronounced orexigenic (appetite-stimulating) effect, and utility in studying the interplay between ghrelin receptor activation, growth hormone dynamics, and feeding behavior.
Research Applications
Where researchers apply it.
— Verified & Documented
Every vial is backed by a Certificate of Analysis.
Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.
Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.